Salute e Benessere

Mile High Labs Raises Series B Equity Financing, Readies for Global CPG…

For the past year, Mile High Labs has been working with leading consumer packaged goods companies to launch pilot CBD products. In June 2020, Mile High Labs became the supplier to Ocean Spray Cranberries, Inc.'s CarryOn™ sparkling water beverages. The following month, the Company launched a line of CBD products with NISA Retail for distribution through its network of over 2,500 independently owned stores across the UK. Mile High Labs expects to announce additional partnerships over the coming…
PR Newswire
05/08/2020 00:19

Colorcon Opens New Technical Centre in Melbourne, Australia to support the…

Tim Horwood, Business Development Manager in Australia, explains the importance of the facility "the new technical service center will provide both large and small customers the opportunity to work directly with Colorcon and for the first time in Australia to conduct laboratory-scale compression and coating trials, using automated coating equipment, saving valuable development time and cost. Tim Horwood, Business Development Manager in Australia, explains the importance of the facility…
PR Newswire
04/08/2020 23:00

Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate

Phase 1 portion of the Phase 1/2 clinical trial evaluated two doses of Novavax' COVID-19 vaccine across two dose levels (5 and 25 µg) in 131 healthy adults ages 18-59 yearsNVX-CoV2373 was generally well-tolerated and had a reassuring safety profileThe vaccine induced neutralization titers in 100% of participantsBoth 5 µg and 25 µg adjuvanted doses generated peak geometric mean titer (GMT) greater than 1:3,300Matrix-M™ adjuvant induced robust polyfunctional CD4 +T cell...
Nasdaq GlobeNewswire
04/08/2020 22:05

Jazz Pharmaceuticals Announces Second Quarter 2020 Financial Results

2020 Total Revenue Guidance Increased to a Range of $2.225 Billion to $2.325 Billion 2020 Total Revenue Guidance Increased to a Range of$2.225 Billionto$2.325 Billion 2020 GAAP EPS Guidance Increased to$3.40-$4.85 2020 Adjusted EPS Guidance Increased to$11.90-$13.00 On Track to Deliver Diversified Top-line Growth with up to Five Product Launches Through 2021 DUBLIN, Aug. 4, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced...
PR Newswire
04/08/2020 22:05

Oncolytics Biotech® Reports 2020 Second Quarter Financial Results and…

Demonstrated clinically that pelareorep reverses the immunosuppressive microenvironments of tumors Demonstrated clinically that pelareorep reverses the immunosuppressive microenvironments of tumors Management hosting a conference call and webcast today at4:30 pm ET SAN DIEGOandCALGARY, Alberta,Aug. 4, 2020/PRNewswire/ -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced its financial results and operational highlights for the quarter endedJune 30,...
PR Newswire
04/08/2020 22:01

Dragonfly Biosciences Terminates Venture Agreement With Borganic Inc/Stillcanna…

PR Newswire
04/08/2020 20:08

Verona Pharma plc: Issue of Equity, PDMR Dealings & Total Voting Rights

LONDON and RALEIGH, N.C., Aug.04, 2020(GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company focused on respiratory diseases, notifies the following transactions by persons discharging managerial responsibilities (“PDMRs”).Issue of Equity An aggregate of 267,296 ordinary shares of 5 pence each (“Ordinary Shares”), represented by 33,412 American Depositary Shares (“ADSs”) following the vesting on...
Nasdaq GlobeNewswire
04/08/2020 19:13

The contract manufacturing market for live biotherapeutics and microbiome…

Manufacturing live biotherapeutic products is both technically challenging and financially demanding; as a result, innovator firms are becoming increasingly reliant on contract service providers to access specialized facilities and optimize overall costs. Manufacturing live biotherapeutic products is both technically challenging and financially demanding; as a result, innovator firms are becoming increasingly reliant on contract service providers to access specialized facilities and optimize...
PR Newswire
04/08/2020 19:00

The Point-of-Care Ultrasound Certification Academy announces Doctors Without…

Inteleos™ is a non-profit certification organization that delivers rigorous assessments and cultivates a global community of professionals dedicated to the highest standards in healthcare and patient safety. Inteleos is the overarching governance and management organization for the American Registry for Diagnostic Medical Sonography® (ARDMS®) the Alliance for Physician Certification and Advancement™ (APCA™) and the Point-of-Care Ultrasound Certification Academy™ which represents over 116,000…
PR Newswire
04/08/2020 18:26

Nerve Repair and Regeneration Market worth $9.7 billion by 2025 - Exclusive…

The Growth in Nerve Regeneration Market is driven mainly by high incidence of nerve injuries, the growing prevalence of neurological disorders, and rising government support for neurologic disorder research. The Growth inNerve Regeneration Market is driven mainly by high incidence of nerve injuries, the growing prevalence of neurological disorders, and rising government support for neurologic disorder research. Neurostimulation and Neuromodulation Devices accounted for the largest...
PR Newswire
04/08/2020 17:30

9 Quiet Materials Science Start-Ups Ready to Change Metal Additive…

The materials portfolio for AM processes was predominantly based on the modification of existing materials and supply chains. Metal powders are the most common form of feedstock used with titanium, steels, aluminum, nickel-based, cobalt-based, copper, precious metals, and more all employed. Titanium is the most significant and there is significant movement in this industry, with expansions (such as Sandvik, Oerlikon, and Tekna), vertical integration within key verticals (such as GE Additive and…
PR Newswire
04/08/2020 17:07

Transactions in connection with share buyback program

Company announcement no. 22 - 204 August 2020 Transactions in connection with share buyback program On May 25, 2020 NTG Nordic Transport Group (“NTG”) announced a share buyback program, as described in Company announcement 09 - 20. The program will be executed in accordance with the principles of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (Market Abuse Regulation) and Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe...
Nasdaq GlobeNewswire
04/08/2020 16:57

Amarin Announces Plans to Maximize Blockbuster Potential of VASCEPA® (icosapent…

Amarin to Build Dedicated Organization to Retain Substantial Value of One of the Most Anticipated Cardiovascular Drug Products in Decades Veteran Cardiovascular Commercial Executive Hired to Lead Focused Launch DUBLIN, Ireland and BRIDGEWATER, N.J., Aug.04, 2020(GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), today announced the company's plans to undertake its own focused commercial launch of VASCEPA® (icosapent ethyl) in Europe. Amarin's plan is subject to review and...
Nasdaq GlobeNewswire
04/08/2020 16:38

Digital Therapeutics Market Size to Reach USD 9.64 Billion by 2026 - Valuates…

The major factors driving the growth of global digital therapeutics are increasing mobile and tablet adoption, growing healthcare applications, growing need to monitor healthcare costs and increasing incidence of chronic diseases. Furthermore, high growth prospects in untapped markets would create substantial profit opportunities for producers in the digital therapeutics industry. The major factors driving the growth of global digital therapeutics are increasing mobile and tablet adoption,...
PR Newswire
04/08/2020 16:30

Telehealth Software Market Rides the High Wave amid Rapid Digitization and…

A massive boost is projected for the market, attributed to the COVID-19 pandemic. As both patients and physicians are averse to physical contact, hospitals and clinics are relying on teleconsulting to diagnose patients without unnecessary exposure. When required, patients only need visit their nearest clinic/hospital for the actual test by taking prior appointments. A massive boost is projected for the market, attributed to the COVID-19 pandemic. As both patients and physicians are averse to...
PR Newswire
04/08/2020 16:30

Cordico Announces Exclusive Partnership With 'Emotional Survival' Author Dr…

"Everyone at Cordico is honored to be working with Dr. Gilmartin," said Dr. David Black, CEO of Cordico. "We're preserving his legacy for future generations of first responders and making his knowledge, wisdom, and winning presentations more accessible than ever before through our technology platforms. Fortunately, our cloud-based platforms will enable us to meet the worldwide demand for his Emotional Survival strategies, which will allow us to help more people serving in the most…
PR Newswire
04/08/2020 16:00

Orthopedic Braces & Support Market witnesses Upsurge in Millennial Customers…

Rising health & fitness concerns have prompted the millennials to engage in sports and exercises involving strenuous muscle activity. Consequently, problems such as sprained ankles, frozen shoulders and stiff limbs are increasing amongst the younger generation, thereby increasing sales of orthopedic braces & support devices. Rising health & fitness concerns have prompted the millennials to engage in sports and exercises involving strenuous muscle activity. Consequently, problems…
PR Newswire
04/08/2020 16:00

Replacement of Traditional Treatment Methods with Cold Laser Therapies to Boost…

ALBANY, N.Y., Aug. 4, 2020 /PRNewswire/ -- The cold laser therapy market may experience increased demand from a plethora of end users such as hospitals, home care, and specialty clinics during the forecast period of 2019-2027. The replacement of traditional treatments with cold laser therapy may bring immense opportunities for increasing the growth rate of the cold laser therapy market. ALBANY, N.Y.,Aug. 4, 2020/PRNewswire/ -- Thecold laser therapy marketmay experience increased...
PR Newswire
04/08/2020 16:00

Oncopeptides starts the phase 2 PORT study comparing peripheral versus central…

For more information, please contact:Klaas Bakker, MD, PhDChief Medical Officer of OncopeptidesE-mail: klaas.bakker@oncopeptides.comCell: +44-7818-523903 For more information, please contact: Klaas Bakker, MD, PhD Chief Medical Officer of Oncopeptides E-mail:klaas.bakker@oncopeptides.comCell: +44-7818-523903 Rein Piir Head of Investor Relations at Oncopeptides E-mail:rein.piir@oncopeptides.com Cell phone: +46-70-853-72 92 The information in the press release is information...
PR Newswire
04/08/2020 15:54

Draft decisions and voting form of joint stock company “GRINDEKS” Extraordinary…

Draft decisions and voting form of joint stock company “GRINDEKS” Extraordinary General Meeting of shareholdersThe Management Board of joint stock company “GRINDEKS”, registration number: 40003034935, legal address: 53 Krustpils street, Riga, Latvia, LV-1057 (hereafter – the Company), considering the Covid-19 pandemic, with the aim to preserve health of shareholders, the Company's employees as well as public in general, encourages all shareholders to participate in the Extraordinary...
Nasdaq GlobeNewswire
04/08/2020 15:43

Mechanical Ventilator Market to Reach $12.54 Bn, Globally, at CAGR 16.5% by…

Download Sample Report with Detailed COVID-19 Impact Analysis at: https://www.alliedmarketresearch.com/request-for-customization/453?reqfor=covid Download Sample Report with Detailed COVID-19 Impact Analysis at: https://www.alliedmarketresearch.com/request-for-customization/453?reqfor=covid Drivers, restrains, and opportunities- Growth in geriatric population, rise in prevalence of chronic respiratory diseases, and increase in government expenditures on healthcare drive the growth...
PR Newswire
04/08/2020 15:30

LaunchPad Medical Rebrands as RevBio and Launches an Updated Website

"Many research partners, investors, and commercial partners felt that our prior name did not adequately express the transformational nature of our Tetranite technology platform," said Brian Hess, CEO of RevBio, Inc. "We believe this new brand will now cast the right light on both the company and its products." "Many research partners, investors, and commercial partners felt that our prior name did not adequately express the transformational nature of our Tetranite…
PR Newswire
04/08/2020 15:19

Changing Approach to Testing Could Ease Burden on Healthcare Systems

While biotech companies work on vaccines and possible treatments and medical device companies progress on patient monitoring, many others have been working on improving testing options. For example, various companies are racing to develop antibody tests, also called serological tests, that can confirm whether someone was infected even after their immune system has cleared the virus. In addition, back in April, Rutgers University researchers had received U.S. government clearance for the first…
PR Newswire
04/08/2020 15:00

Lexogen Appoints Stéphane Barges as New CEO

Stéphane Barges succeeds Alexander Seitz, MD, the company's founder who will take on the role as Chief Innovation Officer. Stéphane Barges succeedsAlexander Seitz, MD, the company's founder who will take on the role as Chief Innovation Officer. "I am delighted to welcome Stéphane to our company," said Dr. Seitz. "He brings on deep knowledge of commercial operations with proven track records in the life sciences and diagnostics industries. With a significant international…
PR Newswire
04/08/2020 15:00